Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Unconventional home remedies can sometimes show surprising results.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New therapies for alopecia areata show potential but need more research.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

More precise, personalized therapies are needed for autoimmune diseases.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

New cytokine-targeted therapies show promise for treating alopecia areata.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.